24 KSE-listed pharmaceutical firms post strong 1st-quarter earnings

Published: 2004-05-20 06:59:00

Updated: 2004-05-20 06:59:00

The combined first-quarter turnover of the 24 major pharmaceutical firms closing fiscal year in December, which is listed in the Korea Stock Exchange, posted 813.6 billion won, up 9.32 percent compared with 744.2 billion won a year earlier and their net income rose 24.56 percent to 74.1 billion w...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK